Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Write for us
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Video
  • Podcasts
  • New for You
  • Covid-19
  • Video
  • Podcasts

Search Results for ad5-ncov

Pakistan Procures 10.6m Doses of Ad5-nCoV for $14 Per Dose but Seeks to Diversify with Other Vaccine Makers

CanSino Biologics, one of China’s leading vaccine makers, inked a deal with Pakistan’s government to sell the Ad5-nCoV vaccine candidate […]

Pakistan Procures 10.6m Doses of Ad5-nCoV for $14 Per Dose but Seeks to Diversify with Other Vaccine Makers
2 months ago
Share
0

CanSino Biologics Inks Deal with Malaysian Holding Company to Prepare Commercialization & Distribution of Ad5-nCoV COVID-19 Vaccine

Indonesia is preparing to support the commercialization of CanSino Biologics’ Ad5-nCoV vaccine candidate as Solution Biologics Sdn Bhd (SOLBIO), a […]

CanSino Biologics Inks Deal with Malaysian Holding Company to Prepare Commercialization & Distribution of Ad5-nCoV COVID-19 Vaccine
4 months ago
Share
0

CanSino Biologics’ Ad5-nCOV Tested in Phase 3 Clinical Trials in Russia

According to local reports out of Russia (Moscow Times), the Phase 3 clinical trial investigating Cansino Biologics’ COVID-19 vaccine candidate, […]

CanSino Biologics’ Ad5-nCOV Tested in Phase 3 Clinical Trials in Russia
4 months ago
Share
0

People’s Liberation Army Helped China Develop Ad5-nCoV COVID-19 Vaccine, While State-Owned SinoPharm’s Vaccine Moves Toward Approval

At present, there are eight COVID-19 vaccines nearing the end of final trials, and four of these are from China. […]

People’s Liberation Army Helped China Develop Ad5-nCoV COVID-19 Vaccine, While State-Owned SinoPharm’s Vaccine Moves Toward Approval
4 months ago
Share
0

Russian Petrovax Embraces Ad5-nCoV & Brings into Russia for Phase 3 Clinical Trials

www.petrocax.com, a Russian pharmaceutical company has inked a deal with CanSino Biologics (CanSinoBIO) to drive Phase 3 clinical trials in Russia. The […]

Russian Petrovax Embraces Ad5-nCoV & Brings into Russia for Phase 3 Clinical Trials
5 months ago
Share
0

Pakistan Selects Ad5-nCoV for Phase 3 COVID-19 Vaccine Trial Led by CRO Dimension Research CRO & SMO

The Drug Regulatory Authority of Pakistan (DRAP) awarded approval to the National institute of Health (NIH) to embrace CanSino Biologics’ […]

Pakistan Selects Ad5-nCoV for Phase 3 COVID-19 Vaccine Trial Led by CRO Dimension Research CRO & SMO
5 months ago
Share
0

Beijing Grants Ad5-nCOV Patent: the First Such COVID-19 Vaccine in China

CanSino Biologics was granted the first patent approval from the Chinese government in Beijing for its COVID-19 vaccine called Ad5-nCOV, […]

Beijing Grants Ad5-nCOV Patent the First Such COVID-19 Vaccine in China
5 months ago
Share
0

Canada Implements Plan B: Embraces Project LightSpeed Securing Access to BNT162 & Mitigating Risk Associated with Ad5-nCoV

Canada made the timely move to strike a deal with the Project Lightspeed sponsors Pfizer and BioNTech SE to diversity […]

Canada Implements Plan B Embraces Project LightSpeed Securing Access to BNT162 & Mitigating Risk Associated with Ad5-nCoV
6 months ago
Share
2

COVID-19 Vaccine Race Moves to Halifax as Canadian Volunteers Eager to Participate in CanSino Biologics Study of Ad5-nCoV

Just hours after an announcement by Justin Trudeau, Prime Minister of Canada, that the nation’s first COVID-19 vaccine clinical trial […]

COVID-19 Vaccine Race Moves to Halifax as Canadian Volunteers Eager to Participate in CanSino Biologics Study of Ad5-nCoV
8 months ago
Share
0

CanSino Biologics’ Ad5-nCoV the First COVID-19 Vaccine to Phase II Clinical Trials

China’s CanSino Biologics recently disclosed that the company was advancing its SARS-CoV-2 vaccine to a Phase II clinical trial making […]

CanSino Biologics’ Ad5-nCoV the First COVID-19 Vaccine to Phase II Clinical Trials
9 months ago
Share
0

Posts navigation

Older posts

Trending News

  • Not Using Ivermectin, One Year In, Is Unethical And Immoral
    Not Using Ivermectin, One Year In, Is Unethical And Immoral
  • New York Supreme Court Judge Order: Give The Patient Ivermectin As Court Battle Leads to Ivermectin for Successful Treatment Against COVID-19
    New York Supreme Court Judge Order: Give The Patient Ivermectin As Court Battle Leads to Ivermectin for Successful Treatment Against COVID-19
  • An Unlikely Nation Is Kicking This Pandemic. Guess Which. Then Why.
    An Unlikely Nation Is Kicking This Pandemic. Guess Which. Then Why.
  • In Far-Flung Places, COVID-19 Is Being Treated Early And Well. Here’s Why Americans Don’t Know This.
    In Far-Flung Places, COVID-19 Is Being Treated Early And Well. Here’s Why Americans Don’t Know This.
  • Growing Momentum for Ivermectin in German Press as Pharmacy Journal Introduces Ivermectin as Possible Treatment for COVID-19
    Growing Momentum for Ivermectin in German Press as Pharmacy Journal Introduces Ivermectin as Possible Treatment for COVID-19

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.